Neurofibromatosis type 1 From diagnosis to follow-up

被引:0
|
作者
Anders, Rebecca [1 ]
Hirsch, Franz Wolfgang [1 ]
Roth, Christian [1 ]
机构
[1] Univ Klinikum Leipzig, Inst Kinderradiol, Liebigstr 20a, D-04103 Leipzig, Germany
来源
RADIOLOGIE | 2022年 / 62卷 / 12期
关键词
Optic glioma; Neurofibroma; Genetic predisposition; Magnetic resonance imaging; Recommendations; OPTIC PATHWAY GLIOMAS; EVOLUTION; CHILDREN; MRI; NF1;
D O I
10.1007/s00117-022-01059-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Neurofibromatosis type 1 (NF1) is a tumor predisposition syndrome and is one of the most common genetic diseases. It is therefore a condition encountered by radiologists in clinical routine. Since the variability of the clinical expression is very high and several organ systems are affected, we present a standardized diagnostic approach in this article. Methods Evaluation of the literature on neurofibromatosis type 1 in the context of radiological examination methods. Results In addition to the frequently known changes in the central and peripheral nervous system such as optic gliomas and plexiform neurofibromas, lesions from the orthopedic spectrum and vascular changes must also be included in the radiological diagnosis. Conclusions Due to the diversity of the clinical picture of NF1, it is reasonable to define an examination strategy which takes into account the needs of radiological routine and also reliably detects the most frequent and prognostically significant pathologies accompanying this disease. In this article, the current recommendations for diagnosis of neurofibromatosis-associated tumors and skeletal changes are summarized, and examination protocols and time intervals are suggested.
引用
收藏
页码:1050 / 1057
页数:8
相关论文
共 50 条
  • [41] Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up
    Felix Distelmaier
    Raimund Fahsold
    Guido Reifenberger
    Martina Messing-Juenger
    Jörg Schaper
    Dominik T. Schneider
    Ulrich Göbel
    Ertan Mayatepek
    Thorsten Rosenbaum
    Child's Nervous System, 2007, 23 : 343 - 347
  • [42] Malignant fibrous histiocytoma in patient with neurofibromatosis, type I. Follow-up: 5 years
    Rivello, GRR
    Cabrera, H
    della Giovanna, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB124 - AB124
  • [43] Fatal glioblastoma multiforme in a patient with neurofibromatosis type I:: the dilemma of systematic medical follow-up
    Distelmaier, Felix
    Fahsold, Raimund
    Reifenberger, Guido
    Messing-Juenger, Martina
    Schaper, Joerg
    Schneider, Dominik T.
    Goebel, Ulrich
    Mayatepek, Ertan
    Rosenbaum, Thorsten
    CHILDS NERVOUS SYSTEM, 2007, 23 (03) : 343 - 347
  • [44] Which type of follow-up?
    Northover, J
    HEPATO-GASTROENTEROLOGY, 2000, 47 (32) : 335 - 336
  • [45] Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7years from diagnosis
    Perdigoto, Ana Luisa
    Preston-Hurlburt, Paula
    Clark, Pamela
    Long, S. Alice
    Linsley, Peter S.
    Harris, Kristina M.
    Gitelman, Steven E.
    Greenbaum, Carla J.
    Gottlieb, Peter A.
    Hagopian, William
    Woodwyk, Alyssa
    Dziura, James
    Herold, Kevan C.
    DIABETOLOGIA, 2019, 62 (04) : 655 - 664
  • [46] Follow-up Report Neurofibromatosis Symposium 2021: Focus on Networking
    Azizi, Amedeo
    PADIATRIE UND PADOLOGIE, 2022, 57 (01): : 36 - 38
  • [47] Tyrosinemia type III: diagnosis and ten-year follow-up
    Cerone, R
    Holme, E
    Schiaffino, MC
    Caruso, U
    Maritano, L
    Romano, C
    ACTA PAEDIATRICA, 1997, 86 (09) : 1013 - 1015
  • [48] Multimodal neuroimaging in diagnosis and follow-up
    Putzer, D.
    Waitz, D.
    Donnemiller, E.
    Virgolini, I.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 : 20 - 23
  • [49] Diagnosis and follow-up of patients with achalasia
    Achkar, E
    Richter, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (03): : 696 - 696
  • [50] Multimodal neuroimaging in diagnosis and follow-up
    D. Putzer
    D. Waitz
    E. Donnemiller
    I. Virgolini
    memo - Magazine of European Medical Oncology, 2009, 2 (Suppl 3) : 20 - 23